Search
Mus musculus skin
go.drugbank.com/drugs/DB10412ApprovedMus musculus skin or pelt is used in allergenic testing.
Categories: Non-Standardized Animal Skin Allergenic ExtractSynonyms: Mus musculus skin, house mouse skin extractIpratropium
go.drugbank.com/drugs/DB00332ApprovedInvestigational[A176939] It is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption. … [A176957] Ipratropium as a therapeutic agent was developed by Boehringer Ingelheim and its first monotherapy product was FDA approved in 1986, while the combination product of ipratropium and [albuterol
Mixtures: NASOVİNE DUO 0,5 MG + 0,6 MG/ML BURUN SPREYİ, ÇÖZELTİ, 1 ADET, SALBUTAMOLO E IPRATROPIO BROMURO EGProducts: ATROVENT 500 MG /2ML, Nasipral 0,3 mg/ml Nasenspray, LösungNADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
go.drugbank.com/bio_entities/BE0000213TargetHumansAccessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly (PubMed:30245030). Complex I functions in the tran...
Polypeptides: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6Synonyms: LYR motif-containing protein 66-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1
go.drugbank.com/bio_entities/BE0001073TargetEnzymeHumansSynthesis and degradation of fructose 2,6-bisphosphate
Polypeptides: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1Function: 6-phosphofructo-2-kinase activity3-keto-L-gulonate-6-phosphate decarboxylase UlaD
go.drugbank.com/bio_entities/BE0001250TargetEscherichia coli (strain K12)Catalyzes the decarboxylation of 3-keto-L-gulonate-6-P into L-xylulose-5-P. Is involved in the anaerobic L-ascorbate utilization.
Polypeptides: 3-keto-L-gulonate-6-phosphate decarboxylase UlaDSynonyms: 3-dehydro-L-gulonate-6-phosphate decarboxylaseATP-binding cassette sub-family C member 6
go.drugbank.com/bio_entities/BE0003640TransporterTargetHumansATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N...
Polypeptides: ATP-binding cassette sub-family C member 6Synonyms: Multidrug resistance-associated protein 6Dual specificity mitogen-activated protein kinase kinase 6
go.drugbank.com/bio_entities/BE0009461TargetHumansThe pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription.
Polypeptides: Dual specificity mitogen-activated protein kinase kinase 6Synonyms: MEK 6, MAPKK 6Ocrelizumab
go.drugbank.com/drugs/DB11988ApprovedInvestigational[A18875,A251745] MS is a chronic, inflammatory, autoimmune disease of the central nervous system that leads to neurological disabilities and a significantly reduced quality of life. … such as a doctor's office.
Products: OCREVUS 300 MG/10 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 2 ADET, OCREVUS 300 MG/10 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 ADETRamipril
go.drugbank.com/drugs/DB00178ApprovedInvestigationalRamipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. … Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII).
Mixtures: RAMIPRIL PIRETA 1A PHA 5/6, RAMIPRIL PIRETA 1A PHA 5/6Categories: Heterocyclic Compounds, 2-RingCetirizine
go.drugbank.com/drugs/DB00341ApprovedInvestigationalOne of the most common uses for this drug is for a condition called _allergic rhinitis_. … The prevalence of allergic rhinitis in the United States is about 15% according to physician diagnoses, and up to 30%, according to self-reported nasal symptoms.
Mixtures: ACERADOX® G, GRIPAC 4®Categories: P-glycoprotein inhibitors, P-glycoprotein substrates